Novartis partners with the Special Olympics to support neuro‑inclusion and build environments where everyone belongs.

Polly Cooper, Clinical Development Function Head, UK

How shared decision-making can support living well from the start with chronic myeloid leukemia

Novartis has announced new long-term Social Impact & Sustainability (SI&S) targets and goals, reinforcing our commitment to go beyond breakthroughs to maximize the impact of our medicines to support inclusive, resilient healthcare systems worldwide.